Daiichi Sankyo Company, Limited (Daiichi Sankyo) announced that it has selected research partners for its 2015 TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project.

TaNeDS, which began in 2011 as part of Daiichi Sankyo’s open innovation programme, selects researchers from universities and public research centres in Japan, and Daiichi Sankyo will soon begin signing agreements with this year’s selected parties to initiate collaborative research.

Daiichi Sankyo RD Novare Co., Ltd. (RD Novare), Daiichi Sankyo’s wholly owned subsidiary, joined TaNeDS to promote the development of novel technology platforms for drug discovery from 2013.